Assignee
ACAD PHARMACEUTICALS INC
US·5 granted patents·1 pending application·7 citations·filing 2018–2024
Top patents by PatentIndex Score
6 records- 0195US11731938B2Ultra short acting anti-arrhythmic agentsACAD PHARMACEUTICALS INC·Filed 2021·Granted Aug 22, 2023·2 cites·21 claims
- 0290US11364213B2Method of initiating or escalating dofetilide dose and formulations thereforACAD PHARMACEUTICALS INC·Filed 2019·Granted Jun 21, 2022·4 cites·20 claims
- 0388US11957648B2Method of initiating or escalating dofetilide dose and formulations thereforACAD PHARMACEUTICALS INC·Filed 2021·Granted Apr 16, 2024·1 cites·9 claims
- 0480US12258309B2Ultra short acting anti-arrhythmic agentsACAD PHARMACEUTICALS INC·Filed 2023·Granted Mar 25, 2025·0 cites·12 claims
- 0568US2025177413A1Short acting esters of ivabradineACAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0647US11389451B2Metolazone emulsion formulationACAD PHARMACEUTICALS INC·Filed 2018·Granted Jul 19, 2022·0 cites·19 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →